Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary cardiac angiosarcoma.

Dhatri Kodali1, Kala Seetharaman

  • 1Division of Hematology, Oncology and Transplantation, University of Minnesota, 420 Delaware St SE, Minneapolis, MN 55455, USA.

Sarcoma
|January 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed-Onset Vitiligo in Metastatic HR+/HER2- Breast Cancer During Long-Term Ribociclib Therapy.

European journal of case reports in internal medicine·2026
Same author

Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis.

Breast cancer (Tokyo, Japan)·2023
Same author

Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017.

Breast cancer research and treatment·2022
Same author

Complete Resolution of a Large, Locally-advanced Cutaneous Squamous Cell Carcinoma with the Immune-modulating PD-1 Inhibitor Pembrolizumab.

Cureus·2020
Same author

MTHFR A1298C and C677T Polymorphisms Are Associated with Increased Risk of Venous Thromboembolism: A Retrospective Chart Review Study.

Acta haematologica·2017
Same author

Gastric Wall Thickening: Do Not Overlook Family History.

The American journal of medicine·2017
Same journal

Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult Patients.

Sarcoma·2024
Same journal

Incidence of Undifferentiated Pleomorphic Sarcoma (UPS) in the United States.

Sarcoma·2024
Same journal

Desmoplastic Small Round Cell Tumors: Clinical Presentation, Molecular Characterization, and Therapeutic Approach of Seven Patients.

Sarcoma·2024
Same journal

ATRX and Its Prognostic Significance in Soft Tissue Sarcoma.

Sarcoma·2024
Same journal

Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the Sacrum.

Sarcoma·2024
Same journal

Exploring the Diagnostic Dilemma of Indeterminate Pulmonary Nodules in Patients with Primary Sarcoma of Bone.

Sarcoma·2024
See all related articles

Primary cardiac sarcoma has a poor prognosis, but liposomal doxorubicin shows promise. This chemotherapy may improve survival for patients with cardiac angiosarcoma, a rare and aggressive cancer.

Area of Science:

  • Cardiology
  • Oncology
  • Medical Research

Background:

  • Primary cardiac sarcoma is exceptionally rare, affecting 0.0001% of autopsies.
  • These aggressive tumors typically present with a dismal prognosis and short median survival of 6 months.
  • Conventional treatments like surgery, chemotherapy, and radiotherapy have shown limited success.

Observation:

  • Up to 80% of patients are diagnosed with systemic metastasis.
  • The efficacy of various chemotherapy regimens remains poorly established.
  • Liposomal doxorubicin (PLD) has demonstrated utility in treating soft tissue sarcomas.

Findings:

  • This case report suggests that liposomal doxorubicin (PLD) may be a viable treatment option for cardiac angiosarcoma.
  • PLD offers a potential therapeutic avenue where other treatments have failed.

Related Experiment Videos

Implications:

  • Further research into liposomal doxorubicin for cardiac angiosarcoma is warranted.
  • This finding could lead to improved treatment strategies and survival outcomes for patients with this rare malignancy.
  • Exploring novel therapeutic approaches is crucial for managing aggressive cardiac tumors.